CGP-59326

Overview

CGP-59326 (TRX-13) is a highly potent and selective epidermal growth factor receptor ( EGFR ) tyrosine kinase inhibitor ( IC 50 =0.027 μM). CGP-59326 blocks the EGFR signaling pathwa, demonstrating highly selective inhibition of EGFR-dependent tumor cells. CGP-59326 is promising for research of cancers.

Application

Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > JAK/STAT Signaling | Products > Signaling Pathways > Protein Tyrosine Kinase/RTK | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Signaling Pathways > EGFR | Products > Signaling Pathways > Tyrosinase

Product Information

• Catalog No.: HY-117852
• CAS No.: 173458-56-5
• Molecular Formula: C14H13ClN4
• Molecular Weight: 272.73
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source